Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece

Vaccine

Volumn 29, Issue 38, 2011, Pages 6664-6669

  Maltezou, Helena C ^a   Katerelos, Panagiotis ^a   Mavrouli, Maria ^b   Lourida, Athanasia ^c   Routsias, John G ^b   Spanakis, Nicholas ^b   Maragos, Antonios ^a   Tedoma, Anastasia ^a   Bassiakos, Yiannis ^d   Koratzanis, Georgios ^b   Mantagos, Stephanos ^e   Metallidis, Simeon ^f   Katragkou, Aspasia ^f   Nikolaidis, Pavlos ^f   Roilides, Emmanuel ^f   Theodoridou, Maria ^c   Tsakris, Athanassios ^b  

^a Hellenic Center for Disease Control and Prevention   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c SISMANOGLIO HOSPITAL   (Greece)

^d UNIVERSITY OF ATHENS   (Greece)

^e UNIVERSITY OF PATRAS   (Greece)

^f ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

Author keywords

Greece; H1N1; Infection; Influenza; Pandemic; Seroprevalence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; GEOGRAPHIC DISTRIBUTION; GREECE; HUMAN; INFANT; INFECTION RISK; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROEPIDEMIOLOGY; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHY; GREECE; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 80051666141     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.098     Document Type: Article

References (33)

1. Schnitzler S.U., Schnitzler P. An update on swine-origin influenza virus A/H1N1: a review. Virus Genes 2009, 39:279-292.
2. Novel Swine-origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. New Engl J Med 2009, 361:102.
3. World Health Organization Pandemic (H1N1) 2009 - update 112 2011, [last accessed: February 2, 2011]. Available at:. http://www.who.int/csr/don/2010_08_06/en/index.html.
4. Efstathiou P., Tseroni M., Baka A., Manolidou Z., Karageorgou K., Sypsa V., et al. Deaths and hospitalizations related to 2009 pandemic influenza A (H1N1) - Greece, May 2009-February 2010. MMWR Morb Mortal Weekly Rep 2010, 59:682-686.
5. Nicoll A., Sprenger M. The end of the pandemic - what will be the pattern of influenza in the 2010-11 European winter and beyond?. Euro Surveill 2010, 15(32). pii=19637.
6. Morens D.M., Taubenerger J.K., Fauci A.S. The 2009 H1N1 pandemic influenza virus: what next?. MBio 2010, 1. pii:e002211-10.
7. European Centre for Diseases Control Forward look risk assessment 2011, [last accessed: February 2, 2011]. Available at:. http://www.ecdc.europa.eu/en/healthtopics/H1N1/Documents/1003_RA_forward_look_influenza.pdf.
8. Seroprevalence of the 2009 influenza A (H1N1) pandemic in New Zealand 2011, [last accessed: February 2, 2011]. Available at:. http://www.moh.govt.nz/moh.nsf/pagesmh/10124/$File/seroprevalence-flu-2009.pdf.
9. Mavrouli M.D., Routsias J.G., Maltezou H.C., Spanakis N., Tsakris A. Estimation of seroprevalence of the pandemic H1N1 2009 influenza virus using a novel virus-free ELISA assay for the detection of specific antibodies. Viral Immunol 2011, 24:221-226.
10. Garten R.J., Davis C.T., Russel C.A., Shu B., Lindstrom S., Balish A., et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325:197-201.
11. Hellenic statistics authority 2011, [last accessed: February 2, 2011]. Available at:. http://www.statistics.gr/portal/page/portal/ESYE/PAGE-database.
12. Maltezou H.C. Nosocomial influenza: new concepts and practice. Curr Opin Infect Dis 2008, 21:337-343.
13. Viboud C., Miller M., Olson D., Osterholm M., Simonsen L. Preliminary estimates of mortality and years lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLoS Curr 2010, RRN1153.
14. Miller M.A., Viboud C., Balinska M., Simonsen L. The signature features of influenza pandemics-implications for policy. New Engl J Med 2009, 360:2595-2598.
15. Chowell G., Bettencourt L.M.A., Johnson N., Alonso W.J., Viboud C. The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc R Soc B 2008, 275:501-509.
16. Chowell G., Viboud C., Simonsen L., Miller M.A., Acuna-Soto R. Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations. J Infect Dis 2010, 202:567-575.
17. Andreasen V., Viboud C., Simonsen L. Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008, 197:270-278.
18. Deng Y., Pang X.H., Yang P., Shi W.X., Tian L.L., Liu B.W., et al. Serological survey of the 2009 H1N1 influenza in residents of Beijing, China. Epidemiol Infect 2010, 21(September):1-7.
19. Hancock K., Veguilla V., Lu X., Zhong W., Butler E.N., Sun H., et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New Engl J Med 2009, 361.
20. Miller E., Hoschler K., Hardelid P., Stanford E., Andrews N., Zambon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010, 375:1100-1108.
21. Tantale B.V., Pawar S.D., Gurav Y.K., Chadha M.S., Koratkar S.S., Shelke V.N., et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis 2010, 10:255.
22. Wu J.T., Ma E.S., Lee C.K., Chu D.K., Ho P.L., Shen A.L., et al. The influenza attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010, 51:1184-1191.
23. Hardelid P., Andrews N.J., Hoschler K., Stanford E., Baguelin M., Waight P.A., et al. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess 2010, 14:115-192.
24. Maltezou H.C., Drancourt M. Nosocomial influenza in children. J Hosp Infect 2003, 55:83-91.
25. Maltezou H.C., Dedoukou X., Patrinos S., Maragos A., Poufta S., Gargalianos P., et al. Determinants of intention to get vaccinated against novel (pandemic) influenza A H1N1 among health-care workers in a nationwide survey. J Infect 2010, 61:252-258.
26. Chen M.I., Lee V.J., Lim W.Y., Barr I.G., Lin R.T., Koh G.C., et al. 2009 influenza A(H1N1) seroconversion rate sand risk factors among distinct adult cohorts in Singapure. JAMA 2010, 303:1383-1391.
27. Wright P.F., Sannella E., Shi J.R., Zhu Y., Ikizier M.R., Edwards K.M. Antibody responses after inactivated influenza vaccine in young children. Pediatr Infect Dis J 2008, 27:1004-1008.
28. Song J.Y., Cheong H.J., Hwang I.S., Choi W.S., Jo Y.M., Park D.W., et al. Long-term immunogenicity of influenza among the elderly: risk factors for poor immune response and persistence. Vaccine 2010, 28:3929-3935.
29. Onozuka D., Hagihara A. Spatial and temporal dynamics of influenza outbreaks. Epidemiology 2008, 19:824-828.
30. Viboud C., Bjornstad O.N., Smith D.L., Simonsen L., Miller M.A., Grenfell B.T. Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 2006, 312:447-451.
31. Lowen A.C., Mubareka S., Steel J., Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 2007, 3:1470-1476.
32. Sharman J., Pitzer V.E., Viboud C., Grenfell B.T., Lipsitch M. Absolute humidity and the seasonal onset of influenza in the continental United States. PLoS Biol 2010, 8:e1000316.
33. World Health Organization Summary review of the 2010-2011 northern hemisphere winter influenza season 2011, [last accessed: June 22, 2011]. Available at:. http://www.who.int/csr/disease/influenza/2010_2011_GIP_surveillance_seasonal_review/en/.